A Greer couple is hosting a fundraiser to support a costly gene editing procedure for their two children, who suffer from a ...

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...

Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.

CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...

CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and ...

MeiraGTx Holdings has signed a deal with Eli Lilly , potentially worth over $475 million, granting the pharma giant rights to ...

Researchers in Australia have led a first-in-human trial for a breakthrough gene-editing therapy that halves bad cholesterol ...